Profile

Cover photo
132 followers|29,302 views
AboutPostsPhotosYouTube

Stream

PharmaVOICE

Shared publicly  - 
 
Digital by Design – 3 Ways to Retool Your Business with Technology in 2017
https://attendee.gotowebinar.com/register/8120880012534954754?source=Gplus
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
The Radical Implications of Indication-Specific Pricing 
This paper discusses one of the potentially more impactful new dynamics in the pricing of pharmaceuticals—the advent of indication-specific pricing. Our goal is to provide context to this important change, highlight some of the implications about which biopharma companies should be aware, and leave you with a framework for raising and addressing pertinent questions across …
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
New White Paper on Managing Mature and Generic Products
While development of promising new products is an obvious area of focus for biopharmaceutical companies, maintenance of already established marketed products is a critical activity that cannot be ignored. As products mature, there is high pressure to grow or sustain revenue from established products whilst keeping maintenance costs low. Creating an environment where information from …
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
OnDemand Webinar Now Available - Gene Therapy: Understanding Evolving Coverage and Reimbursement Challenges https://attendee.gotowebinar.com/register/7209998398723181314
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
White Paper - The New CIO Mandate in Life Sciences http://www.pharmavoice.com/whitepapers/new-cio-mandate-life-sciences/
With the dramatic changes in the healthcare ecosystem due to the Affordable Care Act — combined with other trends, such as the rise of generic medicines, continued regulatory pressure and rampant consumer adoption of mobile and digital technologies — life sciences companies are under pressure to change how they do business. Forward thinkers are striving …
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
How Can Pharma Balance Gene Therapy’s Promise and Price? Free Webinar https://attendee.gotowebinar.com/register/7209998398723181314?source=PVsocial
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
OnDemand Webinar - Engaging Gen X and Millennials
There’s a population tsunami approaching: the coming of age of the Gen X and Millennial generations. And it’s fueling the rise of the new Patient Economy. These generations account for about 50% of the U.S. population, and they are a powerful force for change. In the new Patient Economy, how each generation consumes healthcare and …
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
OnDemand Webinar Available - Early Asset Development and Commercialization: Partnering for Success
To be successful in developing a pharmaceutical asset you have to identify the need and define the commercial value early on in the development process, as well as revisiting and refining the value as you progress through the various phases of development. This means understanding what else is coming onto the market from a competitive …
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
Enhanced 3PL: How the right third party logistics partner can optimize business for manufacturers http://www.pharmavoice.com/podcasts/third-party-logistics/
In this episode, Pete Belden talks about the role of third-party logistics in the commercialization process, how manufactures should solve challenges using 3PL partners, and where 3PL services are headed in the future.
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
OnDemand Webinar Now Available - Gene Therapy: Understanding Evolving Coverage and Reimbursement Challenges https://attendee.gotowebinar.com/register/7209998398723181314
1
Add a comment...

PharmaVOICE

Shared publicly  - 
 
Early Asset Development and Commercialization: Partnering for Success - Free Webinar - register now https://attendee.gotowebinar.com/register/6413795849709146113?source=PVsocial
1
Add a comment...

PharmaVOICE

Shared publicly  - 
1
Add a comment...
Story
Tagline
Covering Everything from Molecule to Market